Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Regulus Therapeutics Inc.

    NASDAQ: RGLS · Real-Time Price · USD
    8.16
    0.00 (0.00%)
    At close: Jun 24, 2025, 3:59 PM

    Regulus Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -46.36M -30.04M -28.32M -27.81M
    Depreciation & Amortization
    		 -1.21M 227K 122K 459K
    Stock-Based Compensation
    		 7.74M 2.8M 2.18M 2.92M
    Other Working Capital
    		 -2.63M 228K 660K 660.7K
    Other Non-Cash Items
    		 n/a -16K -52K 46K
    Deferred Income Tax
    		 n/a n/a n/a -662K
    Change in Working Capital
    		 -1.88M 257K 550K 914K
    Operating Cash Flow
    		 -41.67M -26.77M -25.53M -24.13M
    Capital Expenditures
    		 -340K -613K -361K -251K
    Cash Acquisitions
    		 n/a n/a 14.76K n/a
    Purchase of Investments
    		 -83.64M -4.9M -32.76M n/a
    Sales Maturities Of Investments
    		 48M 20M 18M n/a
    Other Investing Acitivies
    		 n/a 3K -14.76K n/a
    Investing Cash Flow
    		 -35.98M 14.49M -15.12M -251K
    Debt Repayment
    		 -1.38M -3.3M n/a -80K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a 26K
    Financial Cash Flow
    		 92.42M 11.82M 4.49M 53.74M
    Net Cash Flow
    		 14.76M -461K -36.16M 29.36M
    Free Cash Flow
    		 -42.01M -27.38M -25.89M -24.38M

    Add to Watchlist